Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Syringes or pen needles
Semaglutide holds a 42% share of the GLP-1 Obesity Home Delivery Injectables Market due to its strong clinical performance, broad regulatory approvals, and patient-friendly dosing regimen
330 (Pt 2), 695699 (1998)
No appeal will succeed Prior authorization attempt wastes 4 to 6 weeks You'll end up paying out-of-pocket anyway Compounded cost ($250-400/month) is lower than brand-name retail ($1,200-1,400/month) Scenario 2: You don't have diabetes and your BMI is 27-29 with no documented comorbidities
Lyophilised shelf life: up to 24 months when stored correctly
US$ 25.88
US$ 29.04
US$ 27.14
